Praveen Anand

2 Patents

• US125595592026

  Targeting Galectin-9 as a Therapeutic Strategy for T-cell Exhaustion in T-cell Acute Lymphoblastic Leukemia

  THE BRIGHAM AND WOMEN'S HOSPITAL, Inc.

  0 cites
• US121877662025

  Compositions and Methods for Treating Sars-cov-2 Infections

  Nference, Inc.

  0 cites